AMANDA SAVAGE: Open Payments
NPI 1871865717 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 51 payments from 13 companies in 2025. Trend: 2023 $422 · 2024 $984 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $270 |
| ABBVIE INC. | 13 | $196 |
| Novo Nordisk Inc | 8 | $151 |
| Lilly USA, LLC | 3 | $70 |
| PFIZER INC. | 4 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| IBSA Pharma Inc. | 2 | $34 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: FARXIGA, UBRELVY, Ozempic, JARDIANCE, NURTEC ODT, AIRSUPRA, Kerendia, Tirosint.
Industry payments across MS — which companies pay providers there.
